Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C19orf66 |
| Upstream (Parents) |
|---|
| (<<) PALMD → C19orf66 |
| (<<) CD1D → C19orf66 |
| (<<) PPAP2B → C19orf66 |
| Downstream (Children) |
|---|
| C19orf66 → LHPP (>>) |
| C19orf66 → SIGIRR (>>) |
| C19orf66 → GAA (>>) |
| C19orf66 → SLC46A3 (>>) |
| C19orf66 → IL11RA (>>) |
| C19orf66 → APOL3 (>>) |
| C19orf66 → IFIT1 (>>) |
| C19orf66 → LOC441204 (>>) |
| C19orf66 → IL18R1 (>>) |
| C19orf66 → ADRB2 (>>) |
| C19orf66 → PAX2 (>>) |
| C19orf66 → MIER2 (>>) |
| C19orf66 → POU6F2 (>>) |
| C19orf66 → HN1L (>>) |
| C19orf66 → LY6E (>>) |
| C19orf66 → SYCE1L (>>) |
| C19orf66 → PCDHA5 (>>) |
| C19orf66 → OASL (>>) |
| C19orf66 → PDK1 (>>) |
| C19orf66 → DSC2 (>>) |
| C19orf66 → MCOLN1 (>>) |
| C19orf66 → SDC3 (>>) |
| C19orf66 → CAMK1 (>>) |
| C19orf66 → SHC2 (>>) |
| C19orf66 → CTSF (>>) |
| C19orf66 → ATAD5 (>>) |
